Active clinical trials

Neovascular Macular Degeneration Treatment Trial

Phase: 3 - B

• Duration: 18 months
• Impact: International
• Treatment: Implantable device for the release of Ranibizumab
• Cost for the patient: €0
• Travel expenses: Covered

Open recruitment

Trial for the treatment of Atrophic Macular Degeneration

• Duration: 18 months
• Impact: International
• Treatment: Gene therapy
• Cost for the patient: €0
• Travel expenses: Covered

Open recruitment

Study for the treatment of dry AMD with loss of photoreceptors

• Phase 3
• Duration: 2 years
• Impact: International
• Treatment: Mitochondrial protection agent
• Cost for the patient: €0
• Travel expenses: Covered

Study activation planned for September/October 2024

Study to evaluate conjunctiva and Tenon's capsule in healthy subjects and patients with wet AMD and/or diabetic macular edema

• Duration: Single visit
• Impact: National
• Treatment: Ophthalmological examination
• Cost for the patient: €0

Study activation planned for October/November 2024

Persistent Corneal Epithelial Defect (PCED)

Study for the treatment of moderate/severe PCED due to Neurotrophic Keratopathy

Phase: 2/3

• Duration: 56 to 84 days
• Impact: International
• Treatment: Ophthalmic gel
• Cost to patient: €0
• Travel expenses: Covered
   

Expected start date: Nov/Dec 2024

Prospective study to assess the clinical outcome of Toric Phakic Intraocular Lens implantation in patients with Moderate/High Myopia with Astigmatism.

• Duration: 3 years
• Impact: International
• Treatment: Implantation of toric phakic intraocular lens
• Cost of lenses for the patient: €0
• Travel expenses: Covered

Study activation scheduled for early 2025

Prospective post-market study to evaluate the performance of Phakic Lens in patients with Myopia.

• Duration: 3 years
• Impact: International
• Treatment: Implantation of intraocular phakic lens patients with myopia
• Cost of lenses for the patient: €0
• Travel expenses: Covered

Study activation scheduled for the end of 2024.

Prospective study to compare outcomes of two Trifocal Toric Lenses in patients with Cataracts and coexisting Astigmatism who wish to be treated for presbyopia.

• Duration: 3 years
• Impact: International
• Treatment: Implantation of trifocal phakic intraocular lens
• Cost of lenses for the patient: €0
• Travel expenses: Covered

Study activation scheduled for 2025.

Study to evaluate the performance of intraocular lenses in patients with cataracts

• Duration: 2 years
• Impact: International
• Treatment: Implantation of a monofocal intraocular lens for patients with cataracts
• Cost of lenses for the patient: €0
• Travel expenses: Covered

Open recruitment

Study to evaluate geographic atrophy in comparison with healthy eyes

• Duration: 1 and a half year
• Impact: International
• Prospective non-interventional study
• Cost for the patient: €0
• Travel expenses: Covered

Open recruitment